# BXP, Inc.: financial statements, quarterly

BXP · NYSE · CIK 1037540 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bxp.md) · [Financials](/companies/bxp/financials.md) · [Filings](/companies/bxp/filings.md) · [Insiders](/companies/bxp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bxp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [824](/filings/0001656423-24-000059.md) | [829 d](/filings/0001037540-26-000006.md) | [839](/filings/0001656423-25-000034.md) | [850](/filings/0001656423-25-000046.md) | [859](/filings/0001037540-25-000013.md) | [859 d](/filings/0001037540-26-000006.md) | [865](/filings/0001037540-26-000019.md) | [868](/filings/0001037540-26-000034.md) | [872](/filings/0001037540-25-000013.md) | [877 d](/filings/0001037540-26-000006.md) | [872](/filings/0001037540-26-000019.md) | [896](/filings/0001037540-26-000034.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [502](/filings/0001656423-24-000059.md) | [502 d](/filings/0001037540-26-000006.md) | [509](/filings/0001656423-25-000034.md) | [509](/filings/0001656423-25-000046.md) | [511](/filings/0001037540-25-000013.md) | [512 d](/filings/0001037540-26-000006.md) | [512](/filings/0001037540-26-000019.md) | [514](/filings/0001037540-26-000034.md) | [517](/filings/0001037540-25-000013.md) | [516 d](/filings/0001037540-26-000006.md) | [506](/filings/0001037540-26-000019.md) | [539](/filings/0001037540-26-000034.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [148](/filings/0001656423-24-000059.md) | [155 d](/filings/0001037540-26-000006.md) | [162](/filings/0001656423-25-000034.md) | [150](/filings/0001656423-25-000046.md) | [163](/filings/0001037540-25-000013.md) | [170 d](/filings/0001037540-26-000006.md) | [163](/filings/0001037540-26-000019.md) | [163](/filings/0001037540-26-000034.md) | [164](/filings/0001037540-25-000013.md) | [163 d](/filings/0001037540-26-000006.md) | [152](/filings/0001037540-26-000019.md) | [153](/filings/0001037540-26-000034.md) |
| Net income | $m | [(112)](/filings/0001656423-24-000059.md) | [120 d](/filings/0001037540-26-000006.md) | [79.9](/filings/0001656423-25-000034.md) | [79.6](/filings/0001656423-25-000046.md) | [83.6](/filings/0001037540-25-000013.md) | [(229) d](/filings/0001037540-26-000006.md) | [61.2](/filings/0001037540-26-000019.md) | [89.0](/filings/0001037540-26-000034.md) | [(122)](/filings/0001037540-25-000013.md) | [248 d](/filings/0001037540-26-000006.md) | [102](/filings/0001037540-26-000019.md) | [68.6](/filings/0001037540-26-000034.md) |
| Diluted EPS | $ per share | [(0.71)](/filings/0001656423-24-000059.md) | not reported | [0.51](/filings/0001656423-25-000034.md) | [0.51](/filings/0001656423-25-000046.md) | [0.53](/filings/0001037540-25-000013.md) | not reported | [0.39](/filings/0001037540-26-000019.md) | [0.56](/filings/0001037540-26-000034.md) | [(0.77)](/filings/0001037540-25-000013.md) | not reported | [0.64](/filings/0001037540-26-000019.md) | [0.43](/filings/0001037540-26-000034.md) |
| Basic EPS | $ per share | [(0.71)](/filings/0001656423-24-000059.md) | not reported | [0.51](/filings/0001656423-25-000034.md) | [0.51](/filings/0001656423-25-000046.md) | [0.53](/filings/0001037540-25-000013.md) | not reported | [0.39](/filings/0001037540-26-000019.md) | [0.56](/filings/0001037540-26-000034.md) | [(0.77)](/filings/0001037540-25-000013.md) | not reported | [0.64](/filings/0001037540-26-000019.md) | [0.43](/filings/0001037540-26-000034.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.9](/filings/0001656423-24-000059.md) | [1.5](/filings/0001037540-26-000006.md) | [0.7](/filings/0001656423-25-000034.md) | [0.7](/filings/0001656423-25-000046.md) | [1.4](/filings/0001037540-25-000013.md) | [1.3](/filings/0001037540-26-000034.md) | [0.4](/filings/0001037540-26-000019.md) | [0.4](/filings/0001037540-26-000034.md) | [0.9](/filings/0001037540-25-000013.md) | [1.5](/filings/0001037540-26-000034.md) | [0.5](/filings/0001037540-26-000019.md) | [0.5](/filings/0001037540-26-000034.md) |
| Total assets | $bn | [24.7](/filings/0001656423-23-000047.md) | [26.0](/filings/0001656423-25-000009.md) | [25.5](/filings/0001656423-24-000028.md) | [25.5](/filings/0001656423-24-000046.md) | [26.4](/filings/0001656423-24-000059.md) | [26.1](/filings/0001037540-26-000006.md) | [25.4](/filings/0001656423-25-000034.md) | [25.6](/filings/0001656423-25-000046.md) | [26.0](/filings/0001037540-25-000013.md) | [26.2](/filings/0001037540-26-000034.md) | [25.1](/filings/0001037540-26-000019.md) | [25.2](/filings/0001037540-26-000034.md) |
| Total liabilities | $bn | [16.7](/filings/0001656423-23-000047.md) | [17.8](/filings/0001656423-25-000009.md) | [17.2](/filings/0001656423-24-000028.md) | [17.2](/filings/0001656423-24-000046.md) | [18.1](/filings/0001656423-24-000059.md) | [18.1](/filings/0001037540-26-000006.md) | [17.6](/filings/0001656423-25-000034.md) | [17.8](/filings/0001656423-25-000046.md) | [18.5](/filings/0001037540-25-000013.md) | [18.5](/filings/0001037540-26-000034.md) | [17.4](/filings/0001037540-26-000019.md) | [17.4](/filings/0001037540-26-000034.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | [0.0](/filings/0001656423-25-000009.md) | not reported | [0.5](/filings/0001656423-24-000046.md) | [0.5](/filings/0001656423-24-000059.md) | [0.5](/filings/0001037540-26-000006.md) | [0.5](/filings/0001656423-25-000034.md) | [0.8](/filings/0001656423-25-000046.md) | [0.8](/filings/0001037540-25-000013.md) | [0.8](/filings/0001037540-26-000034.md) | [0.8](/filings/0001037540-26-000019.md) | [0.8](/filings/0001037540-26-000034.md) |
| Shareholders' equity | $bn | [5.8](/filings/0001656423-23-000047.md) | [5.9](/filings/0001656423-25-000009.md) | [5.9](/filings/0001656423-24-000028.md) | [5.8](/filings/0001656423-24-000046.md) | [5.8](/filings/0001656423-24-000059.md) | [5.4](/filings/0001037540-26-000006.md) | [5.3](/filings/0001656423-25-000034.md) | [5.3](/filings/0001656423-25-000046.md) | [5.0](/filings/0001037540-25-000013.md) | [5.1](/filings/0001037540-26-000034.md) | [5.2](/filings/0001037540-26-000019.md) | [5.2](/filings/0001037540-26-000034.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [301 d](/filings/0001656423-24-000059.md) | [387 d](/filings/0001037540-26-000006.md) | [198](/filings/0001656423-25-000034.md) | [367 d](/filings/0001656423-25-000046.md) | [286 d](/filings/0001037540-25-000013.md) | [384 d](/filings/0001037540-26-000006.md) | [210](/filings/0001037540-26-000019.md) | [353 d](/filings/0001037540-26-000034.md) | [274 d](/filings/0001037540-25-000013.md) | [408 d](/filings/0001037540-26-000006.md) | [156](/filings/0001037540-26-000019.md) | [446 d](/filings/0001037540-26-000034.md) |
| Dividends paid | $m | [172 d](/filings/0001656423-24-000059.md) | [173 d](/filings/0001037540-26-000006.md) | [172](/filings/0001656423-25-000034.md) | [173 d](/filings/0001656423-25-000046.md) | [173 d](/filings/0001037540-25-000013.md) | [173 d](/filings/0001037540-26-000006.md) | [173](/filings/0001037540-26-000019.md) | [173 d](/filings/0001037540-26-000034.md) | [173 d](/filings/0001037540-25-000013.md) | [123 d](/filings/0001037540-26-000006.md) | [124](/filings/0001037540-26-000019.md) | [125 d](/filings/0001037540-26-000034.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [157](/filings/0001656423-23-000047.md) | [157](/filings/0001656423-24-000028.md) | [157](/filings/0001656423-24-000046.md) | [157](/filings/0001656423-24-000059.md) | [157](/filings/0001656423-25-000034.md) | [157](/filings/0001656423-25-000046.md) | [158](/filings/0001037540-25-000013.md) | [159](/filings/0001037540-26-000019.md) | [159](/filings/0001037540-26-000034.md) | [158](/filings/0001037540-25-000013.md) | [159](/filings/0001037540-26-000019.md) | [160](/filings/0001037540-26-000034.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 159,661,556 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001037540-26-000034.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.